دورية أكاديمية
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
| العنوان: | A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer |
|---|---|
| المؤلفون: | Day, DaphneAff1, Aff2, IDs41416023024317_cor1, Park, John J., Coward, JermaineAff4, Aff5, Markman, BenAff1, Aff2, Lemech, CharlotteAff6, Aff7, Kuo, James C.Aff6, Aff7, Prawira, AmyAff7, Aff8, Brown, Michael P.Aff9, Aff10, Bishnoi, Sarwan, Kotasek, Dusan, Strother, R. Matthew, Cosman, RashaAff7, Aff8, Su, Rila, Ma, Yiding, Yue, Zenglian, Hu, Hui-han, Wu, Rachel, Li, Peiqi, Tse, Archie N. |
| المصدر: | British Journal of Cancer. 129(10):1608-1618 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 00070920 15321827 |
|---|---|
| DOI: | 10.1038/s41416-023-02431-7 |